Lv11
48 积分 2023-12-05 加入
Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein–Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases
2小时前
已完结
Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity
14天前
已完结
Structural insight into apelin receptor-G protein stoichiometry
22天前
已完结
Comprehensive computational study in the identification of novel potential cholesterol lowering agents targeting proprotein convertase subtilisin/kexin type 9
1个月前
已完结
Discovery of [5,5′‐bibenzo[d][1,3]dioxol]‐6‐substituted amine derivatives as potent proprotein convertase subtilisin/kexin type 9 inhibitors
1个月前
已完结
Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure
1个月前
已完结
Discovery of Novel Small Molecule Inhibitors Disrupting the PCSK9-LDLR Interaction
1个月前
已完结
CETP Inhibitors: Should We Continue to Pursue This Pathway?
1个月前
已完结
Old target, but new drug: 2nd generation cetp inhibitor, CKD-508
1个月前
已完结
Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling
2个月前
已完结
皖公网安备34019202002308
